These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6336723)

  • 1. Production of migration inhibitory factor by Listeria-immune mouse T lymphocytes, but not B lymphocytes.
    Kearns RJ; Campbell PA
    Int Arch Allergy Appl Immunol; 1983; 70(1):59-64. PubMed ID: 6336723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokine production in primary mixed lymphocyte reactions. I. Characteristics of responding and stimulating cells.
    Landolfo S; Di Matteo C; Capusso A; Negro-Ponzi A; Forni G
    Exp Cell Biol; 1980; 48(3):180-90. PubMed ID: 6989664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of B cell MIF production by T cells and soluble T cell-derived factors.
    Cohen S; Yoshida T
    J Immunol; 1977 Aug; 119(2):719-21. PubMed ID: 328780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen and mitogen induced production of macrophage migration inhibitory factor in the mouse.
    Altboum I; Pick E
    Int Arch Allergy Appl Immunol; 1979; 60(1):29-43. PubMed ID: 378863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on mediator production by highly purified human T and B lymphocytes.
    Rocklin RE; MacDermott RP; Chess L; Schlossman SF; David JR
    J Exp Med; 1974 Nov; 140(5):1303-16. PubMed ID: 4608321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular co-operation in the production of human leucocyte inhibitory factor by lymphocyte subpopulations stimulated with antigens and allogeneic cells.
    Räsänen L
    Immunology; 1979 Aug; 37(4):715-21. PubMed ID: 387577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes.
    Arvilommi H; Räsänen L
    Immunology; 1980 Aug; 40(4):695-700. PubMed ID: 6448804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Listeria monocytogenesis lipids on the mouse lymphocytes in vitro.
    Jakoniuk P; Borowski J
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):603-9. PubMed ID: 6779774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient lymphokine production of newborn lymphocytes.
    Winter HS; Gard SE; Fischer TJ; Bryson YJ; Stiehm ER
    Pediatr Res; 1983 Jul; 17(7):573-8. PubMed ID: 6225985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of three different rat T-cell clones with specificity to Listeria monocytogenes: phenotype, specific proliferation, lymphokine production, and protective capacity in vivo.
    Stolpmann RM; Sperling U; Hahn H
    Cell Immunol; 1986 Sep; 101(2):548-57. PubMed ID: 3093093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell subsets differ in their ability to migrate in vitro and to produce T cell migration inhibitory factor.
    Kowalczyk D; Pryjma J; Zembala M
    Immunol Lett; 1986 Aug; 13(1-2):33-8. PubMed ID: 2944820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators.
    Masucci G; Szigeti R; Stevens D; Masucci MG; Klein E; Petersen J; Bendtzen K; Klein G
    Cell Immunol; 1984 May; 85(2):511-8. PubMed ID: 6325026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly phenotype of lymphocytes producing murine migration inhibitory factor (MIF).
    Kühner AL; Cantor H; David JR
    J Immunol; 1980 Sep; 125(3):1117-9. PubMed ID: 6997376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production.
    Varesio L; Holden HT
    Cell Immunol; 1980 Nov; 56(1):16-28. PubMed ID: 6253087
    [No Abstract]   [Full Text] [Related]  

  • 18. The production of migration inhibition factor by B and T cells of the guinea pig.
    Yoshida T; Sonozaki H; Cohen S
    J Exp Med; 1973 Oct; 138(4):784-97. PubMed ID: 4582841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of macrophage-activating and migration-inhibition factors in vitro by serologically selected and cloned Listeria monocytogenes-specific T cells of the Lyt 1+2- phenotype.
    Sperling U; Kaufmann SH; Hahn H
    Infect Immun; 1984 Oct; 46(1):111-5. PubMed ID: 6434424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.